Albireo Pharma
(NASDAQ) ALBO
This security has been delisted. This page is retained for historical reference.
ALBO News
Is This a MannKind Killer?
Low-Profile Stocks for High Returns
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowALBO Financials
Key Financial Metrics (TTM)
Gross Margin
96.66%
Operating Margin
-304.31%
Net Income Margin
-372.97%
Return on Equity
-84.83%
Return on Capital
-66.53%
Return on Assets
-50.11%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$54.84M
Operating Income
-$122.91M
EBITDA
-$103.27M
Operating Cash Flow
-$115.32M
Capital Expenditure
-$1.24M
Free Cash Flow
-$116.56M
Cash & ST Invst.
$222.48M
Total Debt
$0.00
Albireo Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$9.83M
+168.3%
Gross Profit
$9.22M
+185.2%
Gross Margin
93.78%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
130
N/A
Net Income
-$38.41M
-167.3%
EBITDA
-$35.15M
-154.7%
Quarterly Fundamentals
Total Cash
$222.48M
-15.3%
Total Debt
$0.00
-100.0%
Accounts Receivable
$2.03M
+55.2%
Inventory
$3.15M
+1506.6%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
N/A
Return on Assets
-50.11%
N/A
Return on Invested Capital
-48.10%
N/A
Free Cash Flow
-$29.67M
-7.2%
Operating Cash Flow
-$29.63M
-7.8%